Bibliographic Details
| Title: |
A randomized controlled trial of a group acceptance-based intervention for cancer survivors experiencing anxiety at re-entry (‘Valued Living’): study protocol |
| Authors: |
Joanna J. Arch, Jill L. Mitchell, Sarah R. Genung, Robert Fisher, David J. Andorsky, Annette L. Stanton |
| Source: |
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019) |
| Publisher Information: |
BMC, 2019. |
| Publication Year: |
2019 |
| Collection: |
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| Subject Terms: |
Anxiety, Cancer, Cancer survivorship, Acceptance and commitment therapy, Acceptance, Psycho-oncology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| More Details: |
Abstract Background Anxiety is a common concern of cancer survivors during the transition from active cancer treatment to cancer survivorship (the re-entry phase). This paper presents the study protocol for a novel group-based behavioral intervention to improve mental health, well-being, and medical use outcomes among anxious cancer survivors at re-entry. Methods/Design This two-armed, prospective randomized controlled trial will randomize a minimum of 100 re-entry-phase cancer survivors with moderate to high anxiety to the intervention or a usual care control condition. The intervention is delivered in a group format over 7 weeks; content is based on Acceptance and Commitment Therapy (ACT), an acceptance, mindfulness, and values-based intervention. Participants will be recruited from community cancer care centers and the intervention will be led by the onsite clinical social workers. Participants will be assessed at baseline, mid-intervention, post-intervention, and 3- and 6-month follow-up. ACT participants will complete process measures before the beginning of group sessions 2, 4, and 6; all participants will complete the process measures during the regular assessments. The primary outcome is anxiety symptoms; secondary outcomes include anxiety disorder severity, fear of recurrence, depressive symptoms, cancer-related trauma symptoms, sense of life meaning, vitality/fatigue, and medical utilization. Discussion This clinical trial will provide valuable evidence regarding the efficacy of the group ACT intervention in community oncology settings. Trial registration Clinicaltrials.gov NCT02550925. |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
1471-2407 |
| Relation: |
http://link.springer.com/article/10.1186/s12885-019-5289-x; https://doaj.org/toc/1471-2407 |
| DOI: |
10.1186/s12885-019-5289-x |
| Access URL: |
https://doaj.org/article/af431948e4b4449d9b815682ba9308fd |
| Accession Number: |
edsdoj.f431948e4b4449d9b815682ba9308fd |
| Database: |
Directory of Open Access Journals |
|
Full text is not displayed to guests. |
Login for full access.
|
